Ceramides deriving from sphingomyelin hydrolysis are important mediators of apoptotic signals originating from Fas (APO-1/CD95). However, definitive evidence for the role played by individual sphingomyelinases is still lacking. We have analyzed lymphoblastoid cell lines derived from patients affected by Niemann Pick disease (NPD), an autosomal recessive disorder caused by loss-of-function mutations within the acidic sphingomyelinase (ASM) gene. NPD lymphoblasts, which display normal neutral sphingomyelinase activity, fail to activate ASM in response to Fas cross-linking, unlike normal lymphoblasts. NPD lymphoblasts also fail to accumulate GD3 ganglioside, a downstream mediator of ceramide-induced cell death (De Maria, R., L. Lenti, F. Malisan, F. D'Agostino, B. Tomassini, A. Zeuner, M.R. Rippo, R. Testi. 1997. Science. 277:1652–1655), and display a substantially inefficient apoptosis after Fas cross-linking. Inefficient apoptosis is due to lack of ASM activity, because proximal signaling from Fas in NPD lymphoblasts is not impaired and apoptosis can be efficiently triggered by passing the ASM defect with exogenous ceramides. Moreover, mannose receptor–mediated transfer of ASM into NPD lymphoblasts rescues their ability to transiently activate ASM, accumulate GD3, and rapidly undergo apoptosis after Fas cross-linking. These results provide definitive genetic evidence for the role of ASM in the progression of apoptotic signals originating from Fas.
Skip Nav Destination
Article navigation
16 March 1998
Article|
March 16 1998
Acidic Sphingomyelinase (ASM) Is Necessary for Fas-induced GD3 Ganglioside Accumulation and Efficient Apoptosis of Lymphoid Cells
Ruggero De Maria,
Ruggero De Maria
From the *Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy; and the ‡Department of Human Genetics and Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York 10029
Search for other works by this author on:
Maria Rita Rippo,
Maria Rita Rippo
From the *Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy; and the ‡Department of Human Genetics and Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York 10029
Search for other works by this author on:
Edward H. Schuchman,
Edward H. Schuchman
From the *Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy; and the ‡Department of Human Genetics and Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York 10029
Search for other works by this author on:
Roberto Testi
Roberto Testi
From the *Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy; and the ‡Department of Human Genetics and Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York 10029
Search for other works by this author on:
Ruggero De Maria
From the *Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy; and the ‡Department of Human Genetics and Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York 10029
Maria Rita Rippo
From the *Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy; and the ‡Department of Human Genetics and Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York 10029
Edward H. Schuchman
From the *Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy; and the ‡Department of Human Genetics and Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York 10029
Roberto Testi
From the *Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy; and the ‡Department of Human Genetics and Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York 10029
Address correspondence to Roberto Testi, Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata”, 00133 Rome, Italy. Phone: 39-6-72596503; Fax: 39-6-72596505; E-mail: [email protected]
Received:
December 05 1997
Revision Received:
January 13 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 187 (6): 897–902.
Article history
Received:
December 05 1997
Revision Received:
January 13 1998
Citation
Ruggero De Maria, Maria Rita Rippo, Edward H. Schuchman, Roberto Testi; Acidic Sphingomyelinase (ASM) Is Necessary for Fas-induced GD3 Ganglioside Accumulation and Efficient Apoptosis of Lymphoid Cells . J Exp Med 16 March 1998; 187 (6): 897–902. doi: https://doi.org/10.1084/jem.187.6.897
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement